Session » 2026 Pediatric Rheumatology Symposium

2:30PM-2:45PM

Abstract Number: 001

Longitudinal Cardiovascular Profiles of Youth with Childhood-onset Systemic Lupus Erythematosus

2:45PM-3:00PM

Abstract Number: 002

Assessing Juvenile Idiopathic Arthritis Healthcare Costs to Advance Value-Based Care

3:00PM-3:15PM

Abstract Number: 003

Dysregulated Macrophage–Fibroblast Crosstalk Identified by Single-Cell RNA-seq in Juvenile Systemic Scleroderma Skin

3:15PM-3:30PM

Abstract Number: 004

Barriers and Facilitators to Teratogenicity Knowledge and Application among Adolescents and Young Adults with Rheumatic Disease

5:11PM-5:16PM

Abstract Number: 018

Abnormal Cortical Grey Matter, White Matter and Subcortical Grey Matter Morphometry is Associated with Disease Features and Quality of Life in Patients with Craniofacial Localized Scleroderma

5:11PM-5:16PM

Abstract Number: 021

Medication Changes and Lung Disease Activity in Systemic JIA: Six-Month Follow-Up of CARRA Registry SJIA-LD Cohort

5:11PM-5:16PM

Abstract Number: 076

Understanding Etiology (CLUE) Study: Whole Genome Sequencing of Childhood-onset Systemic Lupus Erythematosus

5:17PM-5:22PM

Abstract Number: 027

An Examination of Brain-age-related Deviations from Normative Neurodevelopmental Trajectory in Children with Childhood-Onset Systemic Lupus Erythematosus

5:17PM-5:22PM

Abstract Number: 075

Association of Anti-Cytokine Biologics and JAK inhibitors with Bronchoalveolar Fluid Cytokine Profiles in Patients with Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease (SJIA-LD)

5:17PM-5:22PM

Abstract Number: 010

Efficacy and Safety of Emapalumab in Patients with Macrophage Activation Syndrome (MAS) in Systemic Lupus Erythematosus (SLE)

5:23PM-5:28PM

Abstract Number: 046

Antibiotic Exposure and New Diagnosis of Juvenile Idiopathic Arthritis: A Nested Case-Control Study in a Large US Population

5:23PM-5:28PM

Abstract Number: 053

Association between Childhood Opportunity Index and Disparities in Health Care Access and Utilization in Childhood Onset Systemic Lupus Erythematosus

5:23PM-5:28PM

Abstract Number: 030

Musculoskeletal and Nail Ultrasound Findings in Children with Psoriasis: A Case-Control Study

5:29PM-5:34PM

Abstract Number: 017

High-Frequency Ultrasound Evaluation Predicts Disease Activity in Juvenile Localized Scleroderma

5:29PM-5:34PM

Abstract Number: 077

Integrated Spatial Transcriptomics and Proteomics in Reveals Aberrant Lymphoid Networks in Pediatric Lupus Nephritis

5:29PM-5:34PM

Abstract Number: 042

Mindfulness Matters: Early Insights from the Making Mindfulness Matter© in children with Juvenile Idiopathic Arthritis Study.

5:35PM-5:40PM

Abstract Number: 019

Effects of Childhood-Onset Interferon-Driven Autoimmune Disorders on Brain Volume and Executive Function: A Pilot Analysis in JDM and Childhood-Onset SLE

5:35PM-5:40PM

Abstract Number: 035

Healthcare and Medication Utilization Before and After JIA diagnosis in Publicly Insured Children in the United States

5:35PM-5:40PM

Abstract Number: 012

Prevalence and Impact of Adverse Childhood Experiences in Pediatric Systemic Lupus Erythematosus

6:00PM-7:00PM

Abstract Number: 006

Age Matters: Clinical Profile and IVIG Responsiveness in infants with Kawasaki Disease. A multicentric retrospective analysis of 36 patients from North India

6:00PM-7:00PM

Abstract Number: 040

Antiphospholipid Antibody-Mediated Disease: Clinical Characteristics and Outcomes of Catastrophic Antiphospholipid Syndrome and Lupus Anticoagulant Hypoprothrombinemia in a Single Center Pediatric Cohort

6:00PM-7:00PM

Abstract Number: 028

Are You Positive About this Positive ANA Referral? Outcomes for ANA Based Referrals to Pediatric Rheumatology and Subsequent Disease Development

6:00PM-7:00PM

Abstract Number: 054

Assessing Completion of Healthcare Transition: A Retrospective Review of Provider Acknowledgment Following Pediatric Rheumatology Transfer

6:00PM-7:00PM

Abstract Number: 038

Assessment of Disease Activity and Skeletal Damage in Pediatric Chronic Nonbacterial Osteomyelitis and the Effects of Different Treatment Regimens

6:00PM-7:00PM

Abstract Number: 047

Association of anti-DFS70 with autoimmune diseases in children

6:00PM-7:00PM

Abstract Number: 008

Body Mass Index, Neighborhood Opportunity, and Outcomes of Childhood-Onset Lupus

6:00PM-7:00PM

Abstract Number: 014

Bone Microarchitecture Impairment in Juvenile Systemic Lupus Erythematosus Patients: A Comparative Study

6:00PM-7:00PM

Abstract Number: 020

Building Consensus on Key Research Domains and Research Topics in Childhood-onset Neuropsychiatric Lupus: An International Prioritization Initiative

6:00PM-7:00PM

Abstract Number: 052

Case Series: Treatment of Refractory Lung Disease in Systemic Juvenile Idiopathic Arthritis with Cyclophosphamide and Rituximab Combination Therapy

6:00PM-7:00PM

Abstract Number: 043

Challenges of Cognitive Screening and Formal Neuropsychological Evaluation in Youth with Childhood-Onset Systemic Lupus Erythematosus: A Survey of CARRA Providers

6:00PM-7:00PM

Abstract Number: 031

Clinical Characteristics and Diagnostic Predictors of Inflammatory Bowel Disease in Patients with Chronic Nonbacterial Osteomyelitis – A Single Center Retrospective Analysis

6:00PM-7:00PM

Abstract Number: 048

Clinical characteristics of childhood-onset primary Sjögren’s syndrome in South Korea: two centers’ experiences

6:00PM-7:00PM

Abstract Number: 078

Development of A High-Parameter Whole Blood Thrombo-inflammation Flow Cytometry Panel for Research in Pediatric Autoimmune Diseases

6:00PM-7:00PM

Abstract Number: 051

Do Changes in the Weather Influence Joint Pain and Stiffness in Children with Juvenile Idiopathic Arthritis?

6:00PM-7:00PM

Abstract Number: 044

Efficacy of Rituximab Biosimilars in Pediatric ANCA-Associated Vasculitis

6:00PM-7:00PM

Abstract Number: 070

Empowering Voices: Inception of a Parent Led Anatomical Visual Pain Assessment Tool for Juvenile Arthritis

6:00PM-7:00PM

Abstract Number: 062

Evaluating the Relationship Between an Electronic Transition Planning Tool and Transition Success in a Pediatric Rheumatology Clinic

6:00PM-7:00PM

Abstract Number: 009

Functional Lumen Imaging Probe (FLIP) for the Assessment of Esophageal Involvement in Juvenile Systemic Sclerosis: Characteristics and Clinical Utility

6:00PM-7:00PM

Abstract Number: 045

Genotypes and Clinical Phenotypes of Monogenic Autoinflammatory Disorders in Michigan

6:00PM-7:00PM

Abstract Number: 036

Giant Aneurysms in Kawasaki Disease: A Large Quarternary Single Center Experience

6:00PM-7:00PM

Abstract Number: 068

Identification of Challenges in the Quality of Referrals to a Pediatric Rheumatology Center: A Retrospective Chart Review

6:00PM-7:00PM

Abstract Number: 060

Impact of Social Determinants of Health on Outcomes in Pediatric Uveitis

6:00PM-7:00PM

Abstract Number: 061

Impacts of Social Drivers of Health on Outcomes for Patients with Pediatric Systemic Lupus Erythematosus

6:00PM-7:00PM

Abstract Number: 063

Improving Pediatric Lupus Patient Education: Patient and Provider Needs Assessment

6:00PM-7:00PM

Abstract Number: 066

Incidence of Juvenile Idiopathic Arthritis in Chile: Estimates from a National Universal Access Program, 2010-2024

6:00PM-7:00PM

Abstract Number: 058

Increasing Reproductive Health Counseling and Screening in a Pediatric Rheumatology Clinic Using Quality Improvement Principles and Diverse Group of Stakeholders

6:00PM-7:00PM

Abstract Number: 073

Interleukin-6 and Interleukin-12 Stimulation Increases Fibroblast Migration in Localized Scleroderma and Healthy Control Primary Fibroblasts

6:00PM-7:00PM

Abstract Number: 056

Journey Maps of the Diagnostic Process: Insights from Caregivers of Patients with Juvenile Idiopathic Arthritis

6:00PM-7:00PM

Abstract Number: 013

Kikuchi-Fujimoto’s Disease in Systemic Lupus Erythematosus: Single-center Experience

6:00PM-7:00PM

Abstract Number: 025

Longitudinal Single Cell Transcriptomic Analysis of Type I and II Interferon (IFN) Response Genes (IRG) in Refractory Juvenile Dermatomyositis (JDM) Patients with Baricitinib Treatment

6:00PM-7:00PM

Abstract Number: 011

Lung Transplant for Pediatric Dermatomyositis Patients with Interstitial Lung Disease: A Single-Center Experience

6:00PM-7:00PM

Abstract Number: 005

Magnetic Resonance Enterography Detected Sacroiliitis in Pediatric Crohn’s Disease: A Retrospective Cohort Study

6:00PM-7:00PM

Abstract Number: 022

Mental Health concerns in Patients with Juvenile Idiopathic Arthritis and Their Caregivers: A Systematic Review

6:00PM-7:00PM

Abstract Number: 032

Methotrexate Response in Systemic JIA: Real-World Evidence from a Tertiary-Care Cohort

6:00PM-7:00PM

Abstract Number: 049

Novel Insights of Brain MRI Features in Neonatal Lupus Erythematosus with Hydrocephalus

6:00PM-7:00PM

Abstract Number: 015

Obinutuzumab Induces Histologic Remission And Deep Kidney Parenchymal B-Cell Depletion In Patients With Lupus Nephritis: Exploratory Analyses From The REGENCY Trial

6:00PM-7:00PM

Abstract Number: 037

Off-the-Shelf Anti-CD19 CAR T-cell Therapy with Reduced or No Conditioning Chemotherapy Demonstrates Efficacy and Tolerability in Systemic Lupus Erythematosus: Meaningful Activity Supports Planned Adolescent Enrollment

6:00PM-7:00PM

Abstract Number: 029

Oral vs Subcutaneous Methotrexate at High Dose for Pediatric Anterior Uveitis

6:00PM-7:00PM

Abstract Number: 041

Pediatric Behçet’s Disease: A 13-Year Single-Center Experience Highlighting Diagnostic Delays and High Neurological Burden

6:00PM-7:00PM

Abstract Number: 057

Pediatric Learners’ Knowledge Retention and Diagnostic Confidence after High-Fidelity Pediatric Rheumatology Simulation

6:00PM-7:00PM

Abstract Number: 034

Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Management Across Countries: A Survey to Inform Future Comparative Effectiveness Research

6:00PM-7:00PM

Abstract Number: 064

Recognizing Paradoxical Psoriasis in TNF-Inhibitor–Treated Pediatric Rheumatic Disease: A Saskatchewan Experience

6:00PM-7:00PM

Abstract Number: 055

Referrals Leading to Rheumatologic Diagnosis in a Pediatric Rheumatology Center: Influence of Referring Provider Practice and Training

6:00PM-7:00PM

Abstract Number: 065

Screening for Social Determinants of Health Identifies Differences Based on Insurance Types in a Single Pediatric Rheumatology Division

6:00PM-7:00PM

Abstract Number: 023

Screening Tools for Spondyloarthropathies among Patients with Inflammatory Bowel Disease: A Scoping Review

6:00PM-7:00PM

Abstract Number: 039

Single-center Experience of Voclosporin Use for Pediatric Lupus Nephritis

6:00PM-7:00PM

Abstract Number: 072

SOCS1 Haploinsufficiency: Functional Evidence Supporting an Expanded Clinical Phenotype

6:00PM-7:00PM

Abstract Number: 067

Standardizing Effective Education and Intervention for Chronic Non-Inflammatory Pain in Children with Juvenile Idiopathic Arthritis: A Quality Improvement Initiative

6:00PM-7:00PM

Abstract Number: 016

Still’s Disease Associated Lung Disease: Experience from a Tertiary Italian Centre

6:00PM-7:00PM

Abstract Number: 007

Subtle Signs, Severe Consequences: Clinical profile of infants with giant coronary aneurysms compared to those with normal coronaries. A multicentric retrospective analysis of infants with Kawasaki disease

6:00PM-7:00PM

Abstract Number: 071

The Association Between Age at Diagnosis and Health-Related Quality of Life in Takayasu Arteritis

6:00PM-7:00PM

Abstract Number: 069

The Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis trial: Baseline cohort characteristics and importance of stakeholder partner-informed knowledge translation and exchange

6:00PM-7:00PM

Abstract Number: 050

The Quiet Beginning: Early Pediatric Systemic Lupus Erythematosus (SLE) Without Nephritis and the Path to Renal Involvement

6:00PM-7:00PM

Abstract Number: 024

Therapeutic Plasma Exchange in Pediatric Autoimmune Encephalitis

6:00PM-7:00PM

Abstract Number: 074

Tissue Protein Expression Profiling of Interferon Gamma and Frizzled-Wnt-related Signaling Show Increased Periadnexal and Perivascular Localization in Juvenile Localized Scleroderma Skin

6:00PM-7:00PM

Abstract Number: 026

Treatment strategies for articular flares in JIA patients receiving biologic therapy

6:00PM-7:00PM

Abstract Number: 059

Use of Multimodal Teaching to Improve Resident Confidence in Evaluating Rheumatic Conditions

2:30PM-2:45PM

Abstract Number: 079

Still’s Disease Associated Lung Disease: Update From the European Registry

2:45PM-3:00PM

Abstract Number: 080

Expansion of Type I IFN-driven ISGhigh Monocytes and Identification of MAS-Associated CD8+ T cell Population During Macrophage Activation Syndrome

4:31PM-4:36PM

Abstract Number: 094

Identification of Distinct Disease Trajectory Patterns in Children with Chronic Nonbacterial Osteomyelitis (CNO) Using Unsupervised Machine Learning on Longitudinal Clinical Data from a Single Cohort of 267 Patients

4:31PM-4:36PM

Abstract Number: 133

Pathologic Lymphangiogenesis in Mouse Model and Patients with Pulmonary Arterial Hypertension

4:31PM-4:36PM

Abstract Number: 126

Unmet Social Needs in Pediatric Rheumatic Disease: A Study of Disparities

4:37PM-4:42PM

Abstract Number: 089

Anti-CD19 CAR-T Cell Therapy for the Treatment of Severe/Refractory Pediatric Autoimmune Diseases: A Single-Center Case Series

4:37PM-4:42PM

Abstract Number: 101

Identifying Intervention Targets to Reduce Emotional Distress and Improve Physical Activity in Juvenile Lupus and Dermatomyositis Patients: Longitudinal Analysis of Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Study Patient-Reported Resiliency Data

4:37PM-4:42PM

Abstract Number: 118

Pain Experience and Treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Systemic Lupus Erythematosus Registry

4:43PM-4:48PM

Abstract Number: 132

AI-Assisted Body-Region Recognition for Localized Scleroderma: the 1st Step in Automated LoSCAT scoring

4:43PM-4:48PM

Abstract Number: 114

Incidence of Inflammatory Arthritis Before and After Inflammatory Bowel Disease Diagnosis: A Population-Based Cohort Study

4:43PM-4:48PM

Abstract Number: 115

KneeMS for Juvenile Idiopathic Arthritis

4:49PM-4:54PM

Abstract Number: 125

Educational Interventions to Increase Transition Preparedness in a Pediatric Rheumatology Clinic

4:49PM-4:54PM

Abstract Number: 104

Identification of Joints with Active Arthritis from Clinical Notes with High Fidelity using a Large Language Model

4:49PM-4:54PM

Abstract Number: 117

Reliability of Pediatric-Specific Musculoskeletal Ultrasound Scanning Protocol for the Detection of Arthritis

4:55PM-5:00PM

Abstract Number: 120

Bridging Evidence and Practice: New Institutional Pathway Increases Primary Intensification Rates for Children with High-Risk Kawasaki Disease

4:55PM-5:00PM

Abstract Number: 098

Investigating S100 Proteins as Biomarkers for Pediatric Localized Scleroderma

4:55PM-5:00PM

Abstract Number: 116

Pilot of Adalimumab Withdrawal (PAW): Preliminary Analysis of Feasibility and Acceptability of Self-Collected Capillary Blood Samples

5:00PM-6:00PM

Abstract Number: 087

A Growing Problem: Factors Associated with Growth Disturbances in Juvenile Localized Scleroderma

5:00PM-6:00PM

Abstract Number: 096

Acute Care Utilization in New-Onset Childhood Systemic Lupus Erythematosus: Insights from a Pilot Study

5:00PM-6:00PM

Abstract Number: 103

Anifrolumab Use in Youngsters with Rheumatic Conditions: Case Series and a Review of the Evidence Base

5:00PM-6:00PM

Abstract Number: 086

APOL1 Focal Segmental Glomerulosclerosis Requiring Renal Transplant, the Burden of Childhood onset Autoimmune and Autoinflammatory Disease

5:00PM-6:00PM

Abstract Number: 122

Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children

5:00PM-6:00PM

Abstract Number: 112

Burden of Latent and Active TB in Pediatric TNF-Inhibitor Therapy: A Decade of Real-World Data from a Tertiary Care Centre

5:00PM-6:00PM

Abstract Number: 090

Characterizing CNS MRI Abnormalities in Pediatric ANCA-Associated Vasculitis

5:00PM-6:00PM

Abstract Number: 106

Clinical Characteristics and Safety Outcomes in Refractory Kawasaki Disease Treated with Second-Dose Infliximab

5:00PM-6:00PM

Abstract Number: 099

Clinical Features of Juvenile Antisynthetase Syndrome: A Single-Center Case Series

5:00PM-6:00PM

Abstract Number: 088

Demographics and Clinical Features of Deficiency of adenosine deaminase 2: A Large Quaternary Single Center Experience

5:00PM-6:00PM

Abstract Number: 084

Early Life Exposures and Risk of Spondyloarthritis: A Population-Based Case-Control Study

5:00PM-6:00PM

Abstract Number: 097

Evaluating Associations between Diffusion Tensor Imaging Metrics and Cognitive Function in Youth with Childhood-Onset Systemic Lupus Erythematosus (cSLE)

5:00PM-6:00PM

Abstract Number: 119

Expansion of Mental Health Screening to Patients with Diverse Rheumatologic Diagnoses in an Outpatient Pediatric Rheumatology Clinic

5:00PM-6:00PM

Abstract Number: 100

Experience with Janus Kinase Inhibitors and Abatacept in Juvenile Dermatomyositis: A Retrospective Study from a Large Tertiary Center

5:00PM-6:00PM

Abstract Number: 108

Gender Diverse Youth Treatment Response to Amplified Musculoskeletal Pain Syndrome Rehabilitation

5:00PM-6:00PM

Abstract Number: 093

HOW DO WE HANDLE STILL’S DISEASE? REAL-LIFE CLINICIANS’ CHOICES FROM THE METAPHOR PROJECT WORLDWIDE SURVEY

5:00PM-6:00PM

Abstract Number: 110

Juvenile Idiopathic Inflammatory Myopathies and Macrophage Activation Syndrome: A Case Series

5:00PM-6:00PM

Abstract Number: 082

Ophthalmic Predictors of Response to Methotrexate Monotherapy in Pediatric Non-Infectious Uveitis

5:00PM-6:00PM

Abstract Number: 085

Outcomes of Oligoarticular Juvenile Idiopathic Arthritis Patients Treated with Intra-articular Glucocorticoids: Can We Predict Successful Treatment?

5:00PM-6:00PM

Abstract Number: 124

Patient perspectives, barriers, and next steps in a health care transition clinic for pediatric to adult rheumatology

5:00PM-6:00PM

Abstract Number: 111

Pediatric chronic nonbacterial osteomyelitis outcomes after NSAID or TNF inhibitor discontinuation, a registry cohort with two year follow up data

5:00PM-6:00PM

Abstract Number: 102

Positive Affect and Emotion Regulation Protect Juvenile-Onset Lupus and Dermatomyositis Patients from Emotional Distress: Longitudinal Analysis of Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Cohort Study Parent-Reported Resiliency Data

5:00PM-6:00PM

Abstract Number: 091

Psychosocial Burden in Juvenile Systemic Sclerosis: Insights from PedQL Outcomes

5:00PM-6:00PM

Abstract Number: 131

Reflections on the Creation of a Transition Clinic and the First 6-months of a Registry for Young Adults with Juvenile Idiopathic Arthritis: The Women’s College Hospital Experience

5:00PM-6:00PM

Abstract Number: 083

Relative Risk of a Thrombotic Event in Janus Kinase Inhibitor Use for JIA using the Epic Cosmos Database

5:00PM-6:00PM

Abstract Number: 121

Representation of Skin of Color Among Pediatric Images in ACR Image Library

5:00PM-6:00PM

Abstract Number: 130

Resilience, Cumulative Social Disadvantage, and Disease Activity in Juvenile Idiopathic Arthritis (JIA)

5:00PM-6:00PM

Abstract Number: 095

Rheum2Fake: Lessons from Severe Nutritional Deficiencies

5:00PM-6:00PM

Abstract Number: 105

Rheumatological Biomarkers and Symptom Progression in Pediatric Systemic Lupus Erythematosus (SLE)

5:00PM-6:00PM

Abstract Number: 113

Risk Assessment for Pediatric Rheumatic Diseases in Children with a History of Kawasaki Disease: A Long-Term Retrospective Comparative Big Data Cohort Study

5:00PM-6:00PM

Abstract Number: 129

Selection of Core Measures in Development of a Childhood Arthritis and Rheumatology Research Alliance based Pediatric Pain Registry for Management of Amplified Musculoskeletal Pain Syndrome

5:00PM-6:00PM

Abstract Number: 127

Setting the Stage for an Effective, Accessible, and Patient-Centered Nature-Based Intervention for Adolescents with Juvenile Idiopathic Arthritis (JIA)

5:00PM-6:00PM

Abstract Number: 107

Targeting Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Real-World Emapalumab Experience Spanning 3 Years

5:00PM-6:00PM

Abstract Number: 109

Tarsitis in Juvenile Idiopathic Arthritis: Clinical characteristics, imaging features, and treatment Response – A multicenter retrospective study

5:00PM-6:00PM

Abstract Number: 123

The Details Matter: A Patient Centered Approach to Overcoming Barriers in a Pediatric to Adult Rheumatology Transition Clinic

5:00PM-6:00PM

Abstract Number: 081

Therapeutic Drug Monitoring in Pediatric Rheumatology: A Survey of Providers in North America

5:00PM-6:00PM

Abstract Number: 092

Treatment-Refractory Juvenile Idiopathic Arthritis: Clinical Features and Biologic/Targeted Synthetic DMARD Utilization Patterns in a Single-Center Cohort

5:00PM-6:00PM

Abstract Number: 128

Trends in Medicaid Enrollment Churn Among Children with Rheumatic Disease Diagnoses, 2018-2023

6:00PM-7:00PM

Abstract Number: 138

Demographic, Clinical and Major Histocompatibility Complex (MHC) variation associated with uveitis development in children with juvenile idiopathic arthritis

6:00PM-7:00PM

Abstract Number: 134

More Than Meets the Eye: Broadening the Clinical Spectrum of RelA Haploinsufficiency

6:00PM-7:00PM

Abstract Number: 137

Preliminary Findings: Single Nuclei RNAseq of Juvenile Dermatomyositis Muscle Biopsies Suggests Unique Myositis Specific Autoantibody Cell Population

6:00PM-7:00PM

Abstract Number: 135

The Blood-CSF-Barrier in SLE: Volume and Blood Flow of the Choroid Plexus and Periventricular Tissue Abnormality Gradients

6:00PM-7:00PM

Abstract Number: 136

Transcriptomic Analysis of Ultrasound-Guided Synovial Biopsies from Patients with Juvenile Idiopathic Arthritis

6:00PM-7:00PM

Abstract Number: 139

Unravelling the Pathogenesis of PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis and cervical Adenitis) Flares through Proteomics in the Salivary Matrix: A Potentially Non-Invasive Milieu for Biomarker Discovery

11:00AM-11:15AM

Abstract Number: 142

Improving Recognition and Management of Glucocorticoid-Induced Adrenal Insufficiency in Pediatric Rheumatology Patients

11:15AM-11:30AM

Abstract Number: 143

Fronto-Cerebellar Features Associate with Cognitive Dysfunction in Childhood-Onset Systemic Lupus Erythematosus

11:30AM-11:45AM

Abstract Number: 140

Adalimumab Tapering is Associated with Short-term, but not Long-term, Advantages for Well-controlled Juvenile Idiopathic Arthritis: A Retrospective Cohort Study using the CARRA Registry

11:45AM-12:00PM

Abstract Number: 141

Age and Activity-Dependent Differences in Intraocular Immune Profile of Chronic Autoimmune Uveitis